1. Home
  2. CVM vs OPI Comparison

CVM vs OPI Comparison

Compare CVM & OPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVM
  • OPI
  • Stock Information
  • Founded
  • CVM 1983
  • OPI 2009
  • Country
  • CVM United States
  • OPI United States
  • Employees
  • CVM N/A
  • OPI N/A
  • Industry
  • CVM Biotechnology: Biological Products (No Diagnostic Substances)
  • OPI Real Estate Investment Trusts
  • Sector
  • CVM Health Care
  • OPI Real Estate
  • Exchange
  • CVM Nasdaq
  • OPI Nasdaq
  • Market Cap
  • CVM 18.1M
  • OPI 16.6M
  • IPO Year
  • CVM 1987
  • OPI 2009
  • Fundamental
  • Price
  • CVM $9.53
  • OPI $0.22
  • Analyst Decision
  • CVM
  • OPI
  • Analyst Count
  • CVM 0
  • OPI 0
  • Target Price
  • CVM N/A
  • OPI N/A
  • AVG Volume (30 Days)
  • CVM 386.2K
  • OPI 615.0K
  • Earning Date
  • CVM 08-14-2025
  • OPI 07-30-2025
  • Dividend Yield
  • CVM N/A
  • OPI 13.42%
  • EPS Growth
  • CVM N/A
  • OPI N/A
  • EPS
  • CVM N/A
  • OPI N/A
  • Revenue
  • CVM N/A
  • OPI $466,972,000.00
  • Revenue This Year
  • CVM N/A
  • OPI N/A
  • Revenue Next Year
  • CVM N/A
  • OPI N/A
  • P/E Ratio
  • CVM N/A
  • OPI N/A
  • Revenue Growth
  • CVM N/A
  • OPI N/A
  • 52 Week Low
  • CVM $1.98
  • OPI $0.18
  • 52 Week High
  • CVM $39.30
  • OPI $2.48
  • Technical
  • Relative Strength Index (RSI)
  • CVM 65.33
  • OPI 42.18
  • Support Level
  • CVM $8.04
  • OPI $0.23
  • Resistance Level
  • CVM $9.42
  • OPI $0.25
  • Average True Range (ATR)
  • CVM 0.94
  • OPI 0.01
  • MACD
  • CVM -0.05
  • OPI -0.00
  • Stochastic Oscillator
  • CVM 90.37
  • OPI 12.00

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

About OPI Office Properties Income Trust of Beneficial Interest

Office Properties Income Trust is a United States-based real estate investment trust. Its property portfolio is mainly composed of single-tenant office buildings, as well as multitenant properties, which are leased to parties of high credit quality characteristics. Its major tenant is the U.S. government, followed by other smaller government entities and corporations. The company's properties are spread across the United States. The company has only one segment which is direct ownership of real estate properties.

Share on Social Networks: